Ionis Pharmaceuticals Inc (NASDAQ:IONS), a leader in RNA-targeted drug discovery and development, has seen a recent insider transaction according to a SEC Filing.

Related Keywords

, Ionis Pharmaceuticals Inc , Gurufocus Value , Drug Discovery And Development , Nsider Transaction , Atricko 39 Neil , Urufocus , Fec Filing ,